The burgeoning digital marketplace has presented novel avenues for accessing prescription substances, including the stimulant Adderall, primarily administered for attention deficit hyperactivity disorder (ADHD). While supporters of cognitive enhancement argue that these substances can improve focus and productivity, ethical concerns escalate surrou